Status:
NOT_YET_RECRUITING
Impact of Smell Testing on Health Outcomes
Lead Sponsor:
Monell Chemical Senses Center
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Olfactory Dysfunction
Wellbeing
Eligibility:
All Genders
7+ years
Phase:
PHASE2
Brief Summary
Smell dysfunction is frequent yet neglected. The sense of smell plays a crucial role in signaling disease, safety, and overall quality of life. However, the significance of a functional sense of smell...
Detailed Description
The investigators will recruit participants in cycles for in person or remote participation. Each cycle is characterized by an initial assessment, intervention deployment (smell testing), post-interve...
Eligibility Criteria
Inclusion
- \- Can read and understand English and have access to a reliable internet connection and a smart device or computer for the duration of the experimental sessions, unless they are part of community events in which smart devices are provided
Exclusion
- \- Known intolerance or allergy to any of the odor stimuli used
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07222891
Start Date
November 1 2025
End Date
November 30 2027
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Monell Chemical Senses Center
Philadelphia, Pennsylvania, United States, 19104